Muscle Cell News 4.35 October 21, 2019 | |
| |
TOP STORYCronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Function To investigate the function of titin in human cardiomyocytes (CMs), researchers used CRISPR/Cas9 to generate homozygous truncations in the Z-disk and A-band regions of the TTN gene in human induced pluripotent stem cells. The resulting CMs were characterized using immunostaining, engineered heart tissue mechanical measurements, and single cell force and calcium measurements. [Circulation] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)CARDIAC MUSCLE CELLSInvestigators used single-cell transcriptional profiling to discover that the underlying mechanism of cytokinesis failure was repression of the cytokinesis gene ECT2, downstream of β-adrenergic receptors (β-ARs). Inactivation of the β-AR genes and administration of the β-blocker propranolol increased cardiomyocyte division in neonatal mice, which increased the number of cardiomyocytes and conferred benefit after myocardial infarction in adults. [Sci Transl Med] Full Article The authors report that matured hydratase subunit A (HADHA)ll mutant cardiomyocytes treated with an endogenous mixture of fatty acids manifested the disease phenotype: defective calcium dynamics and repolarization kinetics which resulted in a pro-arrhythmic state. Single cell RNA-seq revealed a cardiomyocyte developmental intermediate, based on metabolic gene expression. [Nat Commun] Full Article Living Myofibroblast-Silicon Composites for Probing Electrical Coupling in Cardiac Systems Scientists hybridized cardiac myofibroblasts with silicon nanowires and used these engineered hybrids to synchronize the electrical activity of cardiomyocytes, studying heterocellular bioelectric coupling in vitro. They injected the engineered myofibroblasts into heart tissues and showed their ability to seamlessly integrate into contractile tissues in vivo. [Proc Natl Acad Sci USA] Abstract Researchers showed that controlled stoichiometric expression of Gata4, Hand2, Mef2c, and Tbx5 significantly enhanced contractile cardiomyocyte reprogramming over previously defined stoichiometric expression of GMT or uncontrolled expression of GHMT. [Sci Rep] Full Article Insertion of miR-499 target sites in the construct enabled investigators to enrich human embryonic stem cell-derived cardiomyocytes in culture. A deterministic non-linear model was developed and validated with experimental data, to predict the outcome for each treatment cycle and the number of treatment cycle repetitions required to achieve completely purified cTNT-positive cells. [Sci Rep] Full Article SKELETAL MUSCLE CELLSH9C2 cells treated by hypoxia/reoxygenation were used to establish in vitro ischemic-reperfusion model. The siRNA for XIST and miR-133 mimics, inhibitor and SOCS2 recombinant plasmids were used to transfect the cells. Cell apoptosis was determined by flow cytometry analysis and cell viability was used for MTT assay. [Mol Ther Nucleic Acids] Abstract | Full Article Scientists investigated the effects of cis-5-Tetradecenoic (cis-5) and myristi (Myr) on mitochondrial bioenergetics and Ca2+ homeostasis in rat skeletal muscle. cis-5 and Myr decreased ADP-stimulated and CCCP-stimulated (uncoupled) respiration, especially when mitochondria were supported by NADH-linked as compared to FADH2-linked substrates. [Toxicol In Vitro] Abstract Muscle Tissue Engineering in Fibrous Gelatin: Implications for Meat Analogs To produce meat analogs, researchers cultured bovine aortic smooth muscle cells and rabbit skeletal muscle myoblasts in gelatin fiber scaffolds, then used immunohistochemical staining to verify that both cell types attached to gelatin fibers and proliferated in scaffold volumes. Short-length gelatin fibers promoted cell aggregation, whereas long fibers promoted aligned muscle tissue formation. [npj Sci Food] Full Article SMOOTH MUSCLE CELLSInvestigators discovered that TRIM7 expression was robustly induced in platelet-derived growth factor type BB-treated vascular smooth muscle cells (VSMCs) and human atherosclerotic plaques. Functional approaches established that knockdown of TRIM7 inhibited proliferation and migration of VSMCs, as well as arrested the cell cycle at G1-S, thus suppressing atherosclerosis progression. [IUBMB Life] Abstract The viability of human umbilical vein endothelial cells and smooth muscle cells on resveratrol-loaded scaffolds was evaluated. Findings demonstrated that resveratrol-loaded nanofibers resulted in not only appropriate antithrombotic properties but also formation a monolayer of endothelial cells on the scaffold surface and lower smooth muscle cell growth. [Biomed Mater] Abstract Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & ESC & iPSC News. | |
| |
REVIEWSVascularized and Innervated Skeletal Muscle Tissue Engineering Due to the complex vascular and neural anatomy within skeletal muscle, regeneration of functional vasculature and nerves is vital for muscle recovery following volumetric muscle loss (VML) injuries. The authors summarize the current state of the field of skeletal muscle tissue engineering using 3D constructs for VML treatment with a focus on studies that have promoted vascular and neural regeneration within the muscle tissue post-VML. [Adv Healthc Mater] Abstract Visit our reviews page to see a complete list of reviews in the muscle cell research field. | |
| |
INDUSTRY NEWSOPKO Health Inc. and Pfizer Inc. announced today that the global Phase III trial evaluating somatrogon dosed once-weekly in pre-pubertal children with growth hormone deficiency met its primary endpoint of non-inferiority to daily GENOTROPIN® for injection, as measured by annual height velocity at 12 months. [OPKO Health Inc.] Press Release Nonprofit CureDuchenne Launches Biobank to Fuel Research for Duchenne Muscular Dystrophy CureDuchenne, a global leader in research, patient care, and innovation in improving and extending the lives of those living with Duchenne muscular dystrophy (Duchenne), announced it has initiated the development of a biobank for Duchenne. The CureDuchenne Biobank is dedicated to empowering Duchenne research and the search for a cure for Duchenne that is independent and accessible to all researchers. [CureDuchenne] Press Release Eleven innovative, communit–based programs are helping improve the heart health of people in the areas they serve thanks in part to grants totaling $775,000 from the AstraZeneca HealthCare Foundation’s Connections for Cardiovascular HealthSM program. Many of these organizations also are sharing their cumulative lessons learned and approaches to preventing and controlling cardiovascular disease so that other organizations throughout the country may benefit. [AstraZeneca HealthCare Foundation] Press Release | |
| |
POLICY NEWSBrexit Hits UK Science Funding and Workforce The first figures have emerged demonstrating that Brexit uncertainty has adversely affected UK research. They show Britain’s annual share of EU research funding has fallen by nearly a third since 2015. [The BBC] Editorial Scientific Integrity Bill Advances in US House with Bipartisan Support Despite their failure to attract a single Republican co-sponsor, Democrats in Congress have long insisted that a bill to strengthen scientific integrity across US government agencies takes a bipartisan stance and is not a veiled attack on the Trump administration’s attitude toward science. That claim of bipartisanship took a big step forward as the science committee of the US House of Representatives tweaked the bill to satisfy key Republicans on the panel. [ScienceMagazine] Editorial
| |
EVENTSNEW Linking Cells, the Cytoskeleton and the Nucleus in Mechanobiology, Aging and Disease Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Researcher – Genome Editing in Cardiac Microtissues (The Jackson Laboratory) NEW Research Scientists – Cardiac and Neuronal Cell Differentiation (Evotec) Postdoctoral Fellow – Skeletal Muscle (Harvard Medical School) Scientific Associate – Cardiac Cell Therapy (Avery Therapeutics) Research Scientist – Metabolic & Muscle Diseases (Regeneron) Research Scientist – Gene Therapy for Neuromuscular Disorders (Vertex Pharmaceuticals) Researcher – Skeletal Muscle Mechanics and Energetics (University of California, Riverside) Senior Scientist – Small Molecule Therapeutics (Almac Group) Assistant Professor – Applied Cardiovascular Physiology (York University) Assistant Specialist – Cardiovascular Medicine (University of California, Davis) Research Scientist – Cellular Electrophysiology (Duke University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Muscle Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|